Tag: Amphivena Therapeutics Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Amphivena Therapeutics Inc.

Amphivena Expands Executive Team

Added to Collection on: 2019-03-04 22:03:45

Tags for this article:

Biotechnology
Pharmaceutical industry
Pharmacy
Eli Lilly and Company
Specialty drugs
Cancer immunotherapy
Biopharmaceutical
Life Sciences
Van Vlasselaer
Amphivena Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Amphivena's Human Proof-of-Concept Data for AMV564 in Relapsed/Refractory AML Updated at ...

Added to Collection on: 2019-06-30 21:07:30

Tags for this article:

Clinical medicine
Oncology
RTT
Leukemia
Cancer
Cancer treatments
Myeloid-derived suppressor cell
7+3
Amphivena Therapeutics Inc.
Acute myeloid leukemia
Myelodysplastic syndrome
Chemotherapy regimen
Camidanlumab tesirine

Click the tags to see associated articles and topics

View Article Details
Amphivena Therapeutics lands $62 mln Series C

Added to Collection on: 2019-09-23 22:37:30

Tags for this article:

Amphivena Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Amphivena Closes $62 Million Series C Financing to Expand the Clinical Development of AMV564 ...

Added to Collection on: 2019-09-23 20:56:15

Tags for this article:

Branches of biology
Cell biology
Myeloid-derived suppressor cell
MDSC
Acute myeloid leukemia
Tumors of the hematopoietic and lymphoid tissues
Myelodysplastic syndrome
CD33
Cancer immunotherapy
Amphivena Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Amphivena Therapeutics appoints president and CEO

Added to Collection on: 2019-12-02 02:22:30

Tags for this article:

Tumors of the hematopoietic and lymphoid tissues
Cancer immunotherapy
Acute myeloid leukemia
Cell biology
Curtis L. Ruegg
Amphivena Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Amphivena Reports Data on Phase 1 Study of AMV564 at Ash Annual Meeting

Added to Collection on: 2019-12-09 06:41:15

Tags for this article:

Clinical medicine
Branches of biology
Drugs
Acute myeloid leukemia
Myelodysplastic syndrome
CD33
Cancer immunotherapy
MDSC
Cell biology
Antibody-drug conjugates
Orphan drugs
Myeloid-derived suppressor cell
Amphivena Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Novel AML patient selection assay for AMV564, Amphivena's lead therapeutic in hematology ...

Added to Collection on: 2020-12-06 11:37:30

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Monoclonal antibodies
Immunology
Acute myeloid leukemia
Bi-specific T-cell engager
Leukemia
Oncology
Myelodysplastic syndrome
Cancer immunology
Antibody-drug conjugates
Amphivena Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Amphivena Presents New Monotherapy and First Combination Therapy Clinical Data in Solid ...

Added to Collection on: 2021-06-04 13:52:30

Tags for this article:

Cancer treatments
Clinical medicine
Medicine
Cancer immunotherapy
Pembrolizumab
Checkpoint inhibitor
Immunotherapy
Cancer immunology
G1 Therapeutics
SOUTH SAN FRANCISCO
Amphivena Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details